Integrated bioinformatic approach of Balur therapy for breast cancer subtypes

Balur is a topical complementary alternative medicine that can be applied to breast cancer. Balur eliminates free radicals and heavy metals which it found enhance in cancer patients compared with healthy persons. Balur uses materials that potentially can halt cancer progression and development such...

Full description

Saved in:
Bibliographic Details
Main Authors: Aristyani Sherry, Subagjo Saraswati, Rahayu Tintrim, Sumitro Sutiman B.
Format: Article
Language:English
Published: EDP Sciences 2025-01-01
Series:BIO Web of Conferences
Online Access:https://www.bio-conferences.org/articles/bioconf/pdf/2025/05/bioconf_icgrc2025_02008.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832539699242074112
author Aristyani Sherry
Subagjo Saraswati
Rahayu Tintrim
Sumitro Sutiman B.
author_facet Aristyani Sherry
Subagjo Saraswati
Rahayu Tintrim
Sumitro Sutiman B.
author_sort Aristyani Sherry
collection DOAJ
description Balur is a topical complementary alternative medicine that can be applied to breast cancer. Balur eliminates free radicals and heavy metals which it found enhance in cancer patients compared with healthy persons. Balur uses materials that potentially can halt cancer progression and development such as aspirin, coffee, moringa, and tobacco. This study was to describe the complexity of Balur in the biological system of breast cancer subtypes such as luminal A, liminal B, and HER-2, which had been found in high numbers in Indonesia, with an integrative bioinformatic approach. Active compounds found from literature studies were collected and screened by skin permeability variables. For breast cancer subtypes, differential expressed gene (DEG) identification was used to explore the target of Balur compounds. The Cytoscape software was used to construct the network of Balur compounds and target proteins of breast cancer subtypes. Gene Ontology, pathway, docking, hub gene, and survival analysis were applied to investigate the detailed mechanism of Balur to breast cancer in each subtype. The results showed that Balur compounds targeted respectively 68, 86, and 84 genes of luminal A, luminal B, and HER-2. From these target genes, 7 Balur compounds had higher binding energy than chemotherapy compounds when they docked with hub genes from each subtype. In conclusion, this study explained the pharmacological mechanisms of Balur therapy, which has great potential as a complementary therapy for breast cancer subtypes.
format Article
id doaj-art-93e4b9828b604d2f806f9d7ce56a1aca
institution Kabale University
issn 2117-4458
language English
publishDate 2025-01-01
publisher EDP Sciences
record_format Article
series BIO Web of Conferences
spelling doaj-art-93e4b9828b604d2f806f9d7ce56a1aca2025-02-05T10:43:07ZengEDP SciencesBIO Web of Conferences2117-44582025-01-011540200810.1051/bioconf/202515402008bioconf_icgrc2025_02008Integrated bioinformatic approach of Balur therapy for breast cancer subtypesAristyani Sherry0Subagjo Saraswati1Rahayu Tintrim2Sumitro Sutiman B.3Lembaga Penelitian Peluruhan Radikal BebasLembaga Penelitian Peluruhan Radikal BebasLembaga Penelitian Peluruhan Radikal BebasLembaga Penelitian Peluruhan Radikal BebasBalur is a topical complementary alternative medicine that can be applied to breast cancer. Balur eliminates free radicals and heavy metals which it found enhance in cancer patients compared with healthy persons. Balur uses materials that potentially can halt cancer progression and development such as aspirin, coffee, moringa, and tobacco. This study was to describe the complexity of Balur in the biological system of breast cancer subtypes such as luminal A, liminal B, and HER-2, which had been found in high numbers in Indonesia, with an integrative bioinformatic approach. Active compounds found from literature studies were collected and screened by skin permeability variables. For breast cancer subtypes, differential expressed gene (DEG) identification was used to explore the target of Balur compounds. The Cytoscape software was used to construct the network of Balur compounds and target proteins of breast cancer subtypes. Gene Ontology, pathway, docking, hub gene, and survival analysis were applied to investigate the detailed mechanism of Balur to breast cancer in each subtype. The results showed that Balur compounds targeted respectively 68, 86, and 84 genes of luminal A, luminal B, and HER-2. From these target genes, 7 Balur compounds had higher binding energy than chemotherapy compounds when they docked with hub genes from each subtype. In conclusion, this study explained the pharmacological mechanisms of Balur therapy, which has great potential as a complementary therapy for breast cancer subtypes.https://www.bio-conferences.org/articles/bioconf/pdf/2025/05/bioconf_icgrc2025_02008.pdf
spellingShingle Aristyani Sherry
Subagjo Saraswati
Rahayu Tintrim
Sumitro Sutiman B.
Integrated bioinformatic approach of Balur therapy for breast cancer subtypes
BIO Web of Conferences
title Integrated bioinformatic approach of Balur therapy for breast cancer subtypes
title_full Integrated bioinformatic approach of Balur therapy for breast cancer subtypes
title_fullStr Integrated bioinformatic approach of Balur therapy for breast cancer subtypes
title_full_unstemmed Integrated bioinformatic approach of Balur therapy for breast cancer subtypes
title_short Integrated bioinformatic approach of Balur therapy for breast cancer subtypes
title_sort integrated bioinformatic approach of balur therapy for breast cancer subtypes
url https://www.bio-conferences.org/articles/bioconf/pdf/2025/05/bioconf_icgrc2025_02008.pdf
work_keys_str_mv AT aristyanisherry integratedbioinformaticapproachofbalurtherapyforbreastcancersubtypes
AT subagjosaraswati integratedbioinformaticapproachofbalurtherapyforbreastcancersubtypes
AT rahayutintrim integratedbioinformaticapproachofbalurtherapyforbreastcancersubtypes
AT sumitrosutimanb integratedbioinformaticapproachofbalurtherapyforbreastcancersubtypes